These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 20185226

  • 1. A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
    Kashanian M, Shahpourian F, Zare O.
    Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):47-51. PubMed ID: 20185226
    [Abstract] [Full Text] [Related]

  • 2. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 3. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
    Teichmann A, Apter D, Emerich J, Greven K, Klasa-Mazurkiewicz D, Melis GB, Spaczynski M, Grubb GS, Constantine GD, Spielmann D.
    Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
    [Abstract] [Full Text] [Related]

  • 4. Unscheduled bleeding with continuous oral contraceptive pills: a comparison of progestin dose.
    Kaneshiro B, Edelman A, Carlson NE, Nichols M, Jensen J.
    Contraception; 2012 Jul; 86(1):22-7. PubMed ID: 22176792
    [Abstract] [Full Text] [Related]

  • 5. Update on the metabolic effects of steroidal contraceptives.
    Sondheimer SJ.
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):911-23. PubMed ID: 1778182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
    Masson S, Franssen E, Hilditch JR, Powell MG.
    Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
    [Abstract] [Full Text] [Related]

  • 8. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
    Rubio-lotvin B, Ruiz-moreno JA, Gonzalez-ansorena R.
    Adv Contracept Deliv Syst; 1992 Jan; 8(1-2):75-88. PubMed ID: 12285566
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G.
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [Abstract] [Full Text] [Related]

  • 10. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 11. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB.
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [Abstract] [Full Text] [Related]

  • 12. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB, Koontz SL, Nichols MD, Jensen JT.
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [Abstract] [Full Text] [Related]

  • 13. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM, Zhang HF, Barnowski C, Wan GJ.
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [Abstract] [Full Text] [Related]

  • 14. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
    Reid RL, Fortier MP, Smith L, Mirkin S, Grubb GS, Constantine GD.
    Contraception; 2010 Dec; 82(6):497-502. PubMed ID: 21074011
    [Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
    Kaunitz AM, Archer DF, Mishell DR, Foegh M.
    Am J Obstet Gynecol; 2015 Mar; 212(3):318.e1-8. PubMed ID: 25220709
    [Abstract] [Full Text] [Related]

  • 16. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
    Gaussem P, Alhenc-Gelas M, Thomas JL, Bachelot-Loza C, Remones V, Ali FD, Aiach M, Scarabin PY.
    Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
    Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD.
    Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
    [Abstract] [Full Text] [Related]

  • 18. [A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives].
    Chen JK.
    Shengzhi Yu Biyun; 1987 May; 7(2):11-6. PubMed ID: 12268918
    [Abstract] [Full Text] [Related]

  • 19. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO, Endrikat J, Düsterberg B, Schmidt W, Gerlinger C, Wessel J, Goldstein H, Jespersen J.
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [Abstract] [Full Text] [Related]

  • 20. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
    Creinin MD, Lippman JS, Eder SE, Godwin AJ, Olson W.
    Contraception; 2002 Sep; 66(3):147-52. PubMed ID: 12384201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.